Table 5 Selected studies for MM therapy from 2020 ASH annual meeting

551

Facon et al. [49]

Ixazomib/Len/Dex

III

01850524

549

Kaufman et al. [51]

Dara/Len/Vel/Dex

II

02874742

130

Alsina et al. [57]

BB21217

I

03274219

134

Costello et al. [59]

P-BCMA-101

I/II

03288493

129

Mailankody et al. [62]

ALLO-715

I

04093596

293

Rodriguez et al. [66]

TNB-383B

I

03933735

290

Chari et al. [67]

JNJ-7564

I

03399799

292

Cohen et al. [68]

BFCR4350A

I

03275103

179

Kumar et al. [70]

MEDI2228

I

03489525

724

Van De Donk et al. [72]

Iberdomide with

Dara/Dex or Vel/Dex

I/II

02773030